Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Diagnostics" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Diagnostics for you to read. Along with our medical data and news we also list Diagnostics Clinical Trials, which are updated daily. BioPortfolio also has a large database of Diagnostics Companies for you to search.
Todos Medical has agreed to acquire in vitro diagnostics company Provista Diagnostics for an undisclosed sum. Provista is involved in the development and commercialisation of blood-based proteomic diagnostic, The post Todos Medical to buy in vitro diagnostics company Provista Diagnostics appeared first on NS Medical Devices.
EKF Diagnostics, the global in vitro diagnostics company, announces that it has opened a new Research & Development facility at its Cardiff, UK headquarters. The new Special Projects Laboratory will focus on developing new applications for EKF’s many point-of-care and central laboratory medical products to enable the Company to enter new market sectors, as well as providing additional di...
Kalorama Information estimates that the market for molecular diagnostics is worth $8.7 billion and will reach $12.9 billion by 2024, outpacing growth in traditional in vitro diagnostics. The post Molecular Diagnostics Picks Up the Pace appeared first on GEN - Genetic Engineering and Biotechnology News.
DUBLIN–(BUSINESS WIRE)–The “The World Molecular Diagnostics Market, 8th Edition” report has been added to ResearchAndMarkets.com’s offering. Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has … Continue reading →
Venture capital firm Telegraph Hill Partners has provided $12.5 million for in vitro diagnostics firm Specific Diagnostics. -More-
Hardy Diagnostics, an FDA-licensed and ISO-certified biomedical manufacturer, has formed a partnership with NG Biotech in France. Hardy Diagnostics is now the United States’ authorized distributor of NG The post Hardy Diagnostics introduces NG-Test CARBA 5 for detection of Carbapenemases appeared first on NS Medical Devices.
CoSara Diagnostics and Co-Diagnostics will launch their CoSara in vitro diagnostic products in India beginning Saturday. -More-
3D Med Diagnosis, a recent diagnostics spin-off from 3D Medicines, raised $40 million in its debut funding. 3D Medicines was established in 2010 to concentrate on the three D's cancer care: diagnostics, drugs and data. 3D Med Diagnosis owns the company's diagnostics portfolio that offers next-gen sequencing for early-stage cancer detection and precision medicine diagnosis. Its cancer diagnostics i...
Chembio Diagnostics has agreed to acquire Brazilian point-of-care diagnostics company Orangelife Comercio e Industria. Orangelife is involved in the manufacturing and distribution of point-of-care diagnostics tests for infectious The post Chembio to buy Brazilian point-of-care diagnostics company Orangelife appeared first on NS Medical Devices.
Gradian Diagnostics announced that Molzym GmbH & Co. KG is joining Gradian Diagnostics. Molzym will become the first acquisition, bringing a wide set of products and services due to their wealth of experience and expertise in molecular microbial analysis, and their focus on deep research and automat...
Location: Penzberg, Germany Job Type: Full-Time Employer: Roche Roche Diagnostics is the leading provider of in vitro diagnostics. We have the ambition to continue shaping the industry by developing and providing innovative solutions...
NeuMoDx Molecular has agreed to work with Sentinel Diagnostics to develop molecular diagnostics assays for respiratory infect -More-
Novacyt SA’s protein diagnostics subsidiary Lab21 Ltd. is acquiring Omega Diagnostics Ltd.’s infectious disease business ...
Roche Diagnostics has appointed Matthew Sause to serve as president and CEO of its North America operations. Sause is coming to Indianapolis-based Roche Diagnostics from Gilead Sciences (NASDAQ: GILD), where he is senior vice president and head of global commercial product. His experience includes 17 years at Roche, including time at the company’s diagnostics division. […]
Cambridge HealthTech Institute (CHI) invited me to attend their Next Generation Point of Care Diagnostics Conference and I came away thoroughly impressed with the content, speakers, and organization. Since I chair several conferences a year I know how hard it is to pull off a good one so I’d like to thank CHI for a job well done. Goals & Attendees The goal of the event was to provide a p...
EKF Diagnostics, the global in vitro diagnostics company, announces that it has opened a new Research & Development facility at its Cardiff, UK headquarters.
Molecular diagnostics firm Co-Diagnostics has introduced its CoPrimer test for the 2019-nCoV coronavirus. The research use only (RUO) test can be used by appropriate laboratories, hospitals, and institutions The post Co-Diagnostics introduces CoPrimer test for 2019-nCoV coronavirus appeared first on NS Medical Devices.
Molecular diagnostics firm Asuragen has collaborated with clinical-stage genetic medicines company Wave Life Sciences to develop companion diagnostics for Huntington’s disease (HD). As part of the agreement, the The post Asuragen and Wave partner to develop companion diagnostics for Huntington’s disease appeared first on NS Medical Devices.
Genecast (Beijing) Biotech, a cancer diagnostics company, partnered with Interpace Diagnostics of New Jersey to offer translational studies and clinical trial diagnostics to biopharma companies. According to the agreement, Interpace will offer the diagnostic products/services worldwide except in China, where Genecast will be responsible for them. Founded in 2014, Genecast has developed circulating...
Diagnostics companies around the world – including Novacyt, Roche, Co-Diagnostics and Mammoth Biosciences – are developing and launching tests to...
The combined companies will have revenue drivers of two commercially available diagnostics tools, Cologuard and Oncotype DX.
Location: Zug, Rotkreuz, Switzerland Job Type: Full-Time Employer: Roche Roche Diagnostics is the #1 IVD company globally. The biggest Business Area of Roche Diagnostics - Centralized and Point of Care Solutions (CPS), has the ambiti...
C2N Diagnostics has unveiled positive results from a study of its APTUS-Aβ blood test for identifying the existence of Alzheimer’s pathology in the brain. The diagnostics company said The post C2N Diagnostics’ APTUS-Aβ Blood Test for Alzheimer’s yields positive results appeared first on NS Medical Devices.
The Logix Smart 2019-nCoV research use only test has been introduced by Co-Diagnostics for use in hospitals, labs and other i -More-